← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$250K

Shares

10,000

Price

$25

Filed

Feb 4

Insider

Name

Welgus Howard G.

Title

CIK

0001801050

Roles

Director

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

59,744

Footnotes

The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026. | The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.61 to $25.60, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing Info

Accession No.

0001628280-26-005567

Form Type

4

Issuer CIK

0001787306

Welgus Howard G.'s History

Date Ticker Type Value
2026-04-01 ARQT $239K
2026-03-02 ARQT $257K
2026-02-02 ARQT $250K
2026-01-02 ARQT $290K
2025-12-01 ARQT $302K
2025-11-03 ARQT $253K
2025-10-01 ARQT M $16K
2025-10-01 ARQT $180K
2025-10-01 ARQT $9K
2025-10-01 ARQT M $0

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $495K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$145K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$106K 2026-03-02